These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
246 related articles for article (PubMed ID: 29306479)
1. Site enrollment rate, outcomes, and study drug effects in a multicenter trial. Results from RELAX-AHF. Metra M; Davison BA; Gimpelewicz C; Carubelli V; Felker GM; Filippatos G; Greenberg BH; Hua TA; Liu Z; Pang PS; Ponikowski P; Severin TM; Voors AA; Wang Y; Cotter G; Teerlink JR Int J Cardiol; 2018 Feb; 253():91-96. PubMed ID: 29306479 [TBL] [Abstract][Full Text] [Related]
2. Serelaxin in addition to standard therapy in acute heart failure: rationale and design of the RELAX-AHF-2 study. Teerlink JR; Voors AA; Ponikowski P; Pang PS; Greenberg BH; Filippatos G; Felker GM; Davison BA; Cotter G; Gimpelewicz C; Boer-Martins L; Wernsing M; Hua TA; Severin T; Metra M Eur J Heart Fail; 2017 Jun; 19(6):800-809. PubMed ID: 28452195 [TBL] [Abstract][Full Text] [Related]
3. Effect of serelaxin on cardiac, renal, and hepatic biomarkers in the Relaxin in Acute Heart Failure (RELAX-AHF) development program: correlation with outcomes. Metra M; Cotter G; Davison BA; Felker GM; Filippatos G; Greenberg BH; Ponikowski P; Unemori E; Voors AA; Adams KF; Dorobantu MI; Grinfeld L; Jondeau G; Marmor A; Masip J; Pang PS; Werdan K; Prescott MF; Edwards C; Teichman SL; Trapani A; Bush CA; Saini R; Schumacher C; Severin T; Teerlink JR; J Am Coll Cardiol; 2013 Jan; 61(2):196-206. PubMed ID: 23273292 [TBL] [Abstract][Full Text] [Related]
4. Evaluating the Efficacy, Safety, and Tolerability of Serelaxin When Added to Standard Therapy in Asian Patients With Acute Heart Failure: Design and Rationale of RELAX-AHF-ASIA Trial. Sato N; Lam CS; Teerlink JR; Greenberg BH; Tsutsui H; Oh BH; Zhang J; Lefkowitz M; Hua TA; Holbro T; Marshood M; Wang XL; Ge J J Card Fail; 2017 Jan; 23(1):63-71. PubMed ID: 27825893 [TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of serelaxin when added to standard of care in patients with acute heart failure: results from a PROBE study, RELAX-AHF-EU. Maggioni AP; López-Sendón J; Nielsen OW; Hallén J; Aalamian-Mattheis M; Wang Y; Ertl G Eur J Heart Fail; 2019 Mar; 21(3):322-333. PubMed ID: 30604559 [TBL] [Abstract][Full Text] [Related]
6. Effect of serelaxin on mode of death in acute heart failure: results from the RELAX-AHF study. Felker GM; Teerlink JR; Butler J; Hernandez AF; Miller AB; Cotter G; Davison BA; Filippatos G; Greenberg BH; Ponikowski P; Voors AA; Hua TA; Severin TM; Unemori E; Metra M J Am Coll Cardiol; 2014 Oct; 64(15):1591-8. PubMed ID: 25301463 [TBL] [Abstract][Full Text] [Related]
7. Serelaxin, recombinant human relaxin-2, for treatment of acute heart failure (RELAX-AHF): a randomised, placebo-controlled trial. Teerlink JR; Cotter G; Davison BA; Felker GM; Filippatos G; Greenberg BH; Ponikowski P; Unemori E; Voors AA; Adams KF; Dorobantu MI; Grinfeld LR; Jondeau G; Marmor A; Masip J; Pang PS; Werdan K; Teichman SL; Trapani A; Bush CA; Saini R; Schumacher C; Severin TM; Metra M; Lancet; 2013 Jan; 381(9860):29-39. PubMed ID: 23141816 [TBL] [Abstract][Full Text] [Related]
8. Representativeness of RELAX-AHF clinical trial population in acute heart failure. Wang TS; Hellkamp AS; Patel CB; Ezekowitz JA; Fonarow GC; Hernandez AF Circ Cardiovasc Qual Outcomes; 2014 Mar; 7(2):259-68. PubMed ID: 24594552 [TBL] [Abstract][Full Text] [Related]
9. Effects of serelaxin in subgroups of patients with acute heart failure: results from RELAX-AHF. Metra M; Ponikowski P; Cotter G; Davison BA; Felker GM; Filippatos G; Greenberg BH; Hua TA; Severin T; Unemori E; Voors AA; Teerlink JR Eur Heart J; 2013 Oct; 34(40):3128-36. PubMed ID: 23999454 [TBL] [Abstract][Full Text] [Related]
10. Design of the RELAXin in acute heart failure study. Ponikowski P; Metra M; Teerlink JR; Unemori E; Felker GM; Voors AA; Filippatos G; Greenberg B; Teichman SL; Severin T; Mueller-Velten G; Cotter G; Davison BA Am Heart J; 2012 Feb; 163(2):149-55.e1. PubMed ID: 22305830 [TBL] [Abstract][Full Text] [Related]
11. Growth differentiation factor 15 (GDF-15) in patients admitted for acute heart failure: results from the RELAX-AHF study. Cotter G; Voors AA; Prescott MF; Felker GM; Filippatos G; Greenberg BH; Pang PS; Ponikowski P; Milo O; Hua TA; Qian M; Severin TM; Teerlink JR; Metra M; Davison BA Eur J Heart Fail; 2015 Nov; 17(11):1133-43. PubMed ID: 26333529 [TBL] [Abstract][Full Text] [Related]
12. Relationship between clinical trial site enrollment with participant characteristics, protocol completion, and outcomes: insights from the EVEREST (Efficacy of Vasopressin Antagonism in Heart Failure: Outcome Study with Tolvaptan) trial. Butler J; Subacius H; Vaduganathan M; Fonarow GC; Ambrosy AP; Konstam MA; Maggioni A; Mentz RJ; Swedberg K; Zannad F; Gheorghiade M; J Am Coll Cardiol; 2013 Feb; 61(5):571-9. PubMed ID: 23246389 [TBL] [Abstract][Full Text] [Related]
13. Use of High-Sensitivity Troponin T to Identify Patients With Acute Heart Failure at Lower Risk for Adverse Outcomes: An Exploratory Analysis From the RELAX-AHF Trial. Pang PS; Teerlink JR; Voors AA; Ponikowski P; Greenberg BH; Filippatos G; Felker GM; Davison BA; Cotter G; Kriger J; Prescott MF; Hua TA; Severin T; Metra M JACC Heart Fail; 2016 Jul; 4(7):591-599. PubMed ID: 27039129 [TBL] [Abstract][Full Text] [Related]
14. Serelaxin in acute heart failure: Most recent update on clinical and preclinical evidence. Ghosh RK; Banerjee K; Tummala R; Ball S; Ravakhah K; Gupta A Cardiovasc Ther; 2017 Feb; 35(1):55-63. PubMed ID: 27727514 [TBL] [Abstract][Full Text] [Related]
15. Effects of Serelaxin in Patients with Acute Heart Failure. Metra M; Teerlink JR; Cotter G; Davison BA; Felker GM; Filippatos G; Greenberg BH; Pang PS; Ponikowski P; Voors AA; Adams KF; Anker SD; Arias-Mendoza A; Avendaño P; Bacal F; Böhm M; Bortman G; Cleland JGF; Cohen-Solal A; Crespo-Leiro MG; Dorobantu M; Echeverría LE; Ferrari R; Goland S; Goncalvesová E; Goudev A; Køber L; Lema-Osores J; Levy PD; McDonald K; Manga P; Merkely B; Mueller C; Pieske B; Silva-Cardoso J; Špinar J; Squire I; Stępińska J; Van Mieghem W; von Lewinski D; Wikström G; Yilmaz MB; Hagner N; Holbro T; Hua TA; Sabarwal SV; Severin T; Szecsödy P; Gimpelewicz C; N Engl J Med; 2019 Aug; 381(8):716-726. PubMed ID: 31433919 [TBL] [Abstract][Full Text] [Related]
16. Serelaxin in acute heart failure patients with preserved left ventricular ejection fraction: results from the RELAX-AHF trial. Filippatos G; Teerlink JR; Farmakis D; Cotter G; Davison BA; Felker GM; Greenberg BH; Hua T; Ponikowski P; Severin T; Unemori E; Voors AA; Metra M Eur Heart J; 2014 Apr; 35(16):1041-50. PubMed ID: 24316514 [TBL] [Abstract][Full Text] [Related]
17. Relaxin for the treatment of patients with acute heart failure (Pre-RELAX-AHF): a multicentre, randomised, placebo-controlled, parallel-group, dose-finding phase IIb study. Teerlink JR; Metra M; Felker GM; Ponikowski P; Voors AA; Weatherley BD; Marmor A; Katz A; Grzybowski J; Unemori E; Teichman SL; Cotter G Lancet; 2009 Apr; 373(9673):1429-39. PubMed ID: 19329178 [TBL] [Abstract][Full Text] [Related]
18. Effects of serelaxin in acute heart failure patients with renal impairment: results from RELAX-AHF. Liu LC; Voors AA; Teerlink JR; Cotter G; Davison BA; Felker GM; Filippatos G; Chen Y; Greenberg BH; Ponikowski P; Pang PS; Prescott MF; Hua TA; Severin TM; Metra M Clin Res Cardiol; 2016 Sep; 105(9):727-37. PubMed ID: 27017514 [TBL] [Abstract][Full Text] [Related]
19. Cause of Death in Patients With Acute Heart Failure: Insights From RELAX-AHF-2. Loungani RS; Teerlink JR; Metra M; Allen LA; Butler J; Carson PE; Chen CW; Cotter G; Davison BA; Eapen ZJ; Filippatos GS; Gimpelewicz C; Greenberg B; Holbro T; Januzzi JL; Lanfear DE; Pang PS; Piña IL; Ponikowski P; Miller AB; Voors AA; Felker GM JACC Heart Fail; 2020 Dec; 8(12):999-1008. PubMed ID: 33189635 [TBL] [Abstract][Full Text] [Related]
20. Effects of serelaxin on the outcome of patients with or without substantial peripheral edema: A subgroup analysis from the RELAX-AHF trial. Gimpelewicz C; Metra M; Cleland JGF; Szecsödy P; Chang Wun CC; Boer-Martins L; Cotter G; Davison BA; Felker GM; Filippatos G; Greenberg BH; Pang P; Ponikowski P; Severin T; Voors AA; Teerlink JR Am Heart J; 2017 Aug; 190():113-122. PubMed ID: 28760204 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]